LAWSUITS NEWS & LEGAL INFORMATION
Bisphosphonate Drugs
Bisphosphonate drugs have been linked to an increased risk of potentially serious medical conditions. These bisphosphonates side effects could be life-threatening in some patients and extremely traumatic. Some bisphosphonates have been linked to femur fractures and "jaw death" (osteonecrosis). Bisphosphonates lawsuits have been filed against the makers of some osteoporotic medication, alleging patients were not adequately warned about the risks associated with the drugs.
Bisphosphonate drugs are medicines designed to prevent or slow the development of osteoporosis. They are given to patients to prevent bones from losing calcium and other minerals that help keep bones strong. Bisphosphonates are also given to some cancer patients and patients with Paget's disease. Among the drugs in the bisphosphonate class are:
Some of the bisphosphonates are taken orally while others are given intravenously.
Unfortunately, some women were given bisphosphonates even though they had osteopenia—which is often just a normal loss of bone mineral density—rather than osteoporosis. This may have exposed some women to a greater risk of side effects than was necessary and may have resulted in women being on bisphosphonate medications longer than they should have been.
Side effects of some bisphosphonate medications reportedly include an increased risk atypical femur fracture in women who took bisphosphonate medications for longer than five years. Bisphosphonate medications have also been linked to osteonecrosis of the jaw, esophageal cancer and arrhythmia.
Among the side effects reportedly linked to use of bisphosphonate medications are:
Atypical subtrochanteric fractures—fractures that occur in the femur and often occur when the patient does something simple such as stepping off a curb or walking down stairs.
Osteonecrosis of the Jaw (ONJ)—This often occurs after minor dental trauma and involves death of a portion of the patient's jawbone. Symptoms of ONJ include swelling in the face, pain and inflammation of oral tissue, tooth lose, serious infection, exposed bone and numbness in the jaw. In some cases, portions of the jaw must be cut out surgically.
Esophageal Cancer—The FDA reportedly has documented 68 cases of patients developing esophageal cancer after using bisphosphonate medications. Some studies suggest patients taking osteoporosis medications are at twice the risk of esophageal cancer as those in the general population.
Arrhythmia—A 2007 study in the New England Journal of Medicine found that certain bisphosphonates were linked to an increased risk of arrhythmia.
Lawsuits have been filed against the makers of certain bisphosphonate medications, alleging patients were not adequately warned about the risks associated with use of bisphosphonate drugs.
Last updated on
FREE BISPHOSPHONATES LAWSUIT EVALUATION
Send your Bisphosphonates claim to a lawyer who will review your claim at NO COST or obligation.
GET LEGAL HELP NOW
GET LEGAL HELP NOW
Bisphosphonates Side Effects
Unfortunately, some women were given bisphosphonates even though they had osteopenia—which is often just a normal loss of bone mineral density—rather than osteoporosis. This may have exposed some women to a greater risk of side effects than was necessary and may have resulted in women being on bisphosphonate medications longer than they should have been.
Side effects of some bisphosphonate medications reportedly include an increased risk atypical femur fracture in women who took bisphosphonate medications for longer than five years. Bisphosphonate medications have also been linked to osteonecrosis of the jaw, esophageal cancer and arrhythmia.
Osteoporotic Bisphosphonates Side Effects
Atypical subtrochanteric fractures—fractures that occur in the femur and often occur when the patient does something simple such as stepping off a curb or walking down stairs.
Osteonecrosis of the Jaw (ONJ)—This often occurs after minor dental trauma and involves death of a portion of the patient's jawbone. Symptoms of ONJ include swelling in the face, pain and inflammation of oral tissue, tooth lose, serious infection, exposed bone and numbness in the jaw. In some cases, portions of the jaw must be cut out surgically.
Esophageal Cancer—The FDA reportedly has documented 68 cases of patients developing esophageal cancer after using bisphosphonate medications. Some studies suggest patients taking osteoporosis medications are at twice the risk of esophageal cancer as those in the general population.
Arrhythmia—A 2007 study in the New England Journal of Medicine found that certain bisphosphonates were linked to an increased risk of arrhythmia.
Bisphosphonates Lawsuits
Bisphosphonates Side Effects Legal Help
If you or a loved one has suffered damages in this case, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.Last updated on
BISPHOSPHONATES LEGAL ARTICLES AND INTERVIEWS
LawyersandSettlements.com Alerts Public of Dangers of Popular Bone Loss Drugs including Fosamax
Did Merck Know About Fosamax Fracture Risk?
Consumer Reports Concerned About Bisphosphonate Drugs
May 2, 2012
With a steadily aging population, there has never been a greater focus on bone health and osteoporosis prevention. According to the National Osteoporosis Foundation(OPF), 10 million Americans currently suffer from brittle bones, with another 34 million exhibiting signs of low bone density. Women represent 80 percent of those affected, and nearly a quarter of individuals who break a hip do not survive beyond a year following their hip fracture. Given such statistics, osteoporosis prevention drugs, like Fosamax, have become increasingly popular, at the risk of potentially greater prevalence of Fosamax side effects. READ MORE
Did Merck Know About Fosamax Fracture Risk?
April 10, 2013
Merck may have buried data on Fosamax fracture risk, according to media reports of the second Fosamax (Alendronate) lawsuit currently before the courts. According to a report by Bloomberg.com, Paul Pennock, the attorney representing Bernadette Glynn, Merck knew there was a risk of bone brittleness and an increased fracture risk with the osteoporosis drug five years before it was made available to the public. READ MORE
Consumer Reports Concerned About Bisphosphonate Drugs
December 15, 2012
The iconic consumer magazine, Consumer Reports has long been known for compiling the best buys in terms of electronics, automotives and other consumer goods. Lately Consumers Union, which publishes the bastion of consumer advocacy, has been setting its sights on pharmaceutical drugs and medical products. And Consumer Reports has let it be known that it's not happy with bisphosphonate side effects. READ MORE
READ MORE Drugs/Medical Settlements and Legal News